Variant report
Variant | nsv961778 |
---|---|
Chromosome Location | chr2:55659501-55668562 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:64)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr2:55659185-55659546 | K562 | blood: | n/a | n/a |
2 | CBX3 | chr2:55659045-55659624 | HCT-116 | colon: | n/a | n/a |
3 | CBX3 | chr2:55665756-55666104 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr2:55660639-55660797 | HepG2 | liver: | n/a | n/a |
5 | CEBPB | chr2:55666260-55666481 | HepG2 | liver: | n/a | chr2:55666327-55666338 |
6 | CEBPB | chr2:55660788-55660798 | A549 | lung: | n/a | n/a |
7 | CEBPB | chr2:55660671-55660809 | K562 | blood: | n/a | n/a |
8 | CREB1 | chr2:55668553-55669043 | K562 | blood: | n/a | n/a |
9 | CTCF | chr2:55659126-55659507 | A549 | lung: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
10 | CTCF | chr2:55659603-55659625 | GM10248 | blood: | n/a | n/a |
11 | CTCF | chr2:55661723-55661750 | GM13976 | blood: | n/a | n/a |
12 | CTCF | chr2:55661140-55661290 | GM12874 | blood: | n/a | n/a |
13 | CTCF | chr2:55659160-55659521 | H1-hESC | embryonic stem cell: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
14 | CTCF | chr2:55659440-55659590 | GM12864 | blood: | n/a | n/a |
15 | CTCF | chr2:55659152-55659516 | K562 | blood: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
16 | CTCF | chr2:55659096-55659575 | HCT-116 | colon: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
17 | CTCF | chr2:55659161-55659556 | HepG2 | liver: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
18 | CTCF | chr2:55659580-55659730 | AG10803 | skin: | n/a | n/a |
19 | CTCF | chr2:55660040-55660190 | AG10803 | skin: | n/a | n/a |
20 | CTCF | chr2:55659420-55659570 | NHEK | skin: | n/a | n/a |
21 | CTCF | chr2:55659058-55659636 | HCT-116 | colon: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
22 | CTCF | chr2:55659036-55659705 | SK-N-SH | brain: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
23 | CTCF | chr2:55659580-55659730 | AG09319 | gingival: | n/a | n/a |
24 | CTCF | chr2:55659106-55659584 | MCF-7 | breast: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
25 | CTCF | chr2:55659160-55659529 | IMR90 | lung: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
26 | CTCF | chr2:55664920-55665070 | HepG2 | liver: | n/a | n/a |
27 | CTCF | chr2:55659135-55659541 | GM12878 | blood: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
28 | CTCF | chr2:55659075-55659620 | K562 | blood: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
29 | CTCF | chr2:55659209-55659501 | A549 | lung: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
30 | CTCF | chr2:55658237-55659876 | A549 | lung: | n/a | chr2:55659337-55659355 chr2:55659332-55659353 chr2:55659338-55659354 |
31 | GATA1 | chr2:55668290-55669044 | K562 | blood: | n/a | chr2:55668531-55668541 chr2:55668533-55668540 chr2:55668533-55668540 chr2:55668533-55668540 |
32 | JUN | chr2:55659172-55659514 | K562 | blood: | n/a | n/a |
33 | JUND | chr2:55668442-55669013 | K562 | blood: | n/a | n/a |
34 | MAX | chr2:55665914-55665920 | HepG2 | liver: | n/a | n/a |
35 | POLR2A | chr2:55665807-55665907 | HepG2 | liver: | n/a | n/a |
36 | POLR2A | chr2:55665418-55665425 | MCF-7 | breast: | n/a | n/a |
37 | RAD21 | chr2:55659219-55659512 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | RAD21 | chr2:55658967-55659602 | A549 | lung: | n/a | n/a |
39 | RAD21 | chr2:55659111-55659509 | H1-hESC | embryonic stem cell: | n/a | n/a |
40 | RAD21 | chr2:55659079-55659641 | A549 | lung: | n/a | n/a |
41 | RAD21 | chr2:55659103-55659528 | SK-N-SH_RA | brain: | n/a | n/a |
42 | RAD21 | chr2:55659116-55659530 | GM12878 | blood: | n/a | n/a |
43 | RAD21 | chr2:55659071-55659554 | ECC-1 | luminal epithelium: | n/a | n/a |
44 | RAD21 | chr2:55659051-55659575 | ECC-1 | luminal epithelium: | n/a | n/a |
45 | RAD21 | chr2:55659027-55659616 | HepG2 | liver: | n/a | n/a |
46 | RAD21 | chr2:55659135-55659532 | IMR90 | lung: | n/a | n/a |
47 | RAD21 | chr2:55658663-55659797 | SK-N-SH | brain: | n/a | n/a |
48 | RAD21 | chr2:55659189-55659622 | MCF-7 | breast: | n/a | n/a |
49 | RAD21 | chr2:55659007-55659568 | HCT-116 | colon: | n/a | n/a |
50 | RAD21 | chr2:55658951-55659570 | Hela-S3 | cervix: | n/a | n/a |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:55458753..55460899-chr2:55659427..55661705,2 | MCF-7 | breast: | |
2 | chr2:55645665..55649753-chr2:55657366..55660139,6 | K562 | blood: | |
3 | chr2:55653744..55655531-chr2:55659781..55661813,3 | K562 | blood: | |
4 | chr2:55652880..55655236-chr2:55657266..55660173,3 | MCF-7 | breast: | |
5 | chr2:55659643..55661172-chr2:55741607..55744341,2 | MCF-7 | breast: | |
6 | chr2:55462241..55464416-chr2:55656583..55659722,3 | MCF-7 | breast: | |
7 | chr2:55463171..55466180-chr2:55659869..55661423,3 | MCF-7 | breast: | |
8 | chr2:55652771..55655244-chr2:55659480..55661281,2 | K562 | blood: | |
9 | chr2:55647253..55647758-chr2:55659096..55659834,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CCDC88A-1 | chr2:55662292-55662758 | NONHSAT070788 |
No data |
No data |
Variant related genes | Relation type |
---|---|
BTF3P5 | TF binding region |
ENSG00000143947 | chromatin interactions |
ENSG00000162994 | chromatin interactions |
ENSG00000115355 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13415672 | chr2:55659501-55659502 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs146837986 | chr2:55659634-55659635 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs140910354 | chr2:55659707-55659708 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs115156706 | chr2:55659736-55659737 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs186652964 | chr2:55659746-55659747 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs528452973 | chr2:55659793-55659794 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs35846240 | chr2:55659797-55659798 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs374929170 | chr2:55659809-55659810 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs556996459 | chr2:55659817-55659818 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs201481125 | chr2:55659852-55659853 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs563129211 | chr2:55659867-55659868 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs375072892 | chr2:55659869-55659870 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs190237550 | chr2:55659870-55659871 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs557083044 | chr2:55659921-55659922 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs13029621 | chr2:55659970-55659971 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs540088815 | chr2:55659978-55659979 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs182574655 | chr2:55659980-55659981 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs572826679 | chr2:55660000-55660001 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs144638134 | chr2:55660050-55660051 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs555544765 | chr2:55660068-55660069 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs76268639 | chr2:55660069-55660070 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs76373346 | chr2:55660129-55660130 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs564233497 | chr2:55660158-55660159 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs533093092 | chr2:55660166-55660167 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs528205553 | chr2:55660212-55660213 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs72915986 | chr2:55660220-55660221 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs185348952 | chr2:55660228-55660229 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs189712662 | chr2:55660287-55660288 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs568215139 | chr2:55660348-55660349 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs182375333 | chr2:55660349-55660350 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs35883596 | chr2:55660372-55660373 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs372786455 | chr2:55660387-55660388 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs138585086 | chr2:55660394-55660395 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs539625941 | chr2:55660438-55660439 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs569528590 | chr2:55660465-55660466 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs140260645 | chr2:55660495-55660496 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs10187983 | chr2:55660508-55660509 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs189229158 | chr2:55660590-55660591 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs558300884 | chr2:55660633-55660634 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs571726024 | chr2:55660653-55660654 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs12471421 | chr2:55660659-55660660 | Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs369275103 | chr2:55660678-55660679 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs370022907 | chr2:55660682-55660683 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs575423191 | chr2:55660711-55660712 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs552782616 | chr2:55660721-55660722 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs552299474 | chr2:55660792-55660793 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs571061901 | chr2:55660807-55660808 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs193096652 | chr2:55660811-55660812 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs539795610 | chr2:55660821-55660822 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs557690749 | chr2:55660861-55660862 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ependymoma | 20639864 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:55658400-55660600 | Weak transcription | HepG2 | liver |
2 | chr2:55659000-55659600 | Enhancers | Liver | Liver |
3 | chr2:55660600-55661400 | Enhancers | HepG2 | liver |
4 | chr2:55664000-55664200 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr2:55664800-55665200 | Bivalent/Poised TSS | HepG2 | liver |
6 | chr2:55665200-55665800 | Flanking Bivalent TSS/Enh | HepG2 | liver |
7 | chr2:55665800-55666000 | Bivalent/Poised TSS | HepG2 | liver |
8 | chr2:55666000-55666200 | Active TSS | HepG2 | liver |
9 | chr2:55666200-55666600 | Enhancers | HepG2 | liver |
10 | chr2:55668400-55668600 | Enhancers | A549 | lung |
11 | chr2:55668400-55669400 | Enhancers | K562 | blood |